C-Path Board Member Paula Olsiewski Honored as AAAS 2018 Elected Fellow Paula Olsiewski, Ph.D., program director at the Alfred P. Sloan Foundation and Critical Path Institute board member, was named a 2
In Recognition of 10th Anniversary, Raymond Woosley and Janet Woodcock Address CPAD Consortium’s 2018 Annual Meeting and Regulatory Science Workshop At its 10th Annual Meeting and Regulatory Science Workshop, November 13, 2018, in Bethesda, MD, C-Path’s Critical Path for Alzhe
CPTR Newsletter – December 2018 CPTR Newsletter – December 2018 In this issue: In the Spotlight: TB-ReFLECT Manuscript Published Updates to the TB
Profiles in Business with Tucson Metro Chamber C-Path President and CEO Martha Brumfield, Ph.D., talks about today’s drug discovery process, C-Path’s global impact a
Doris Duke Charitable Foundation Awards Grant to Critical Path Institute to Advance Therapies for Sickle Cell Disease Contacts: Kissy Black, Critical Path Institute kissyblack@lotosnile.com, 615.298.1144 Kristin Roth-Schrefer, Communications Direct
CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer dis
Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho
First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti
“Improving Clinical Trials to Deliver Better Treatments,” as featured in the Spring 2018 edition of “Progress, the research magazine of Parkinson’s UK”
C-Path Receives COA Qualification from FDA for the Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ) TUCSON, Ariz. – May 7, 2018 — Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou